乳腺癌治疗中异环混合物的进展:新兴趋势,杂交技术,机械路径和SAR洞察力
Akhilesh Gangwar1, Agnidipta Das1, Vikas Jaitak1
1Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda-151401, India.
使用异环化合物的分子杂交表明乳腺癌 (BC) 治疗的前景. 基于triazole的混合物,特别是与英多尔,皮里达津或类固醇相结合时,显示出开发新型抗癌药物的巨大潜力.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 乳腺癌 (BC) 仍然是一个重大的全球健康挑战.
- 现有的FDA批准的药物面临药物耐药性和不良反应等局限性,需要新的治疗策略.
- 分子杂交是一种有前途的方法,可以增强药理活性并改善BC的治疗结果.
研究的目的:
- 审查异环杂交物在乳腺癌 (BC) 治疗中的作用.
- 探索新的分子杂交策略,以开发有效的BC治疗方法.
- 为了确定改善抗癌药物设计的关键药理特征和机制.
主要方法:
- 关于1995年至2024年研究的综合文献综述 在PubMed.
- 包括关键的异环混合物类,如金胺,三醇,醇,胺,氨酸,β-碳醇,阿泽,异素,素和核心混合物.
- 分析结构-活性关系,抗亡机制和蛋白质-连接体相互作用.
主要成果:
- 基于triazole的异环混合物成为BC治疗中特别有效的支架.
- 观察到,当三醇与英多尔,皮里达津和类固醇药物混合时,效果最好.
- 该审查确定了具有突出特征和治疗潜力的特定异环类.
结论:
- 异环杂交体为开发新且更有效的乳腺癌 (BC) 疗法提供了一个有前途的途径.
- 对结构-活性关系和药用特征的进一步调查可以指导下一代抗癌剂的设计.
- 对这些混合分子的持续探索可能会导致BC治疗策略的重大进展.
更多相关视频
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Five-Membered Heterocyclic Aromatic Compounds: Overview
Regioselectivity and Stereochemistry of Hydroboration
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn...
Aromatic Hydrocarbon Cations: Structural Overview
Removing one hydrogen from the intervening CH2 group...
